Macrophages Phenotype Regulated by IL-6 Are Associated with the Prognosis of Platinum-Resistant Serous Ovarian Cancer: Integrated Analysis of Clinical Trial and Omics
Background. The treatment of platinum-resistant recurrent ovarian cancer (PROC) is a clinical challenge and a hot topic. Tumor microenvironment (TME) as a key factor promoting ovarian cancer progression. Macrophage is a component of TME, and it has been reported that macrophage phenotype is related...
Saved in:
Main Authors: | Xiaoqing Wu, Wenping Lu, Chaojie Xu, Cuihong Jiang, Zhili Zhuo, Ruipeng Wang, Dongni Zhang, Yongjia Cui, Lei Chang, Xi Zuo, Ya’nan Wang, Heting Mei, Weixuan Zhang, Mengfan Zhang, Chen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2023/6455704 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction
by: Oz Kilim, et al.
Published: (2025-01-01) -
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial
by: Elena Giudice, et al.
Published: (2024-03-01) -
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01) -
Giant ovarian serous cystadenoma. A case report
by: Jorge Luis Estepa Pérez, et al.
Published: (2011-04-01) -
Surprise Lymph Node Histology in a Patient with Ovarian Serous Carcinoma
by: Jayanthi Karunanithi, et al.
Published: (2020-01-01)